Primary intestinal type mucinous adenocarcinoma of the ovary diagnosed during pregnancy - Maternal and neonatal treatment and outcomes: A case report
The incidence of ovarian cancer during pregnancy is low. Most adnexal tumors removed during pregnancy are benign, with ovarian carcinomas found in approximately 1: 10,000-1: 50,000 pregnancies. Literature on this disease is scarce and consists mostly of retrospective studies and case reports. We rep...
Saved in:
Published in | Frontiers in medicine Vol. 10; p. 1138447 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
29.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The incidence of ovarian cancer during pregnancy is low. Most adnexal tumors removed during pregnancy are benign, with ovarian carcinomas found in approximately 1: 10,000-1: 50,000 pregnancies. Literature on this disease is scarce and consists mostly of retrospective studies and case reports. We report the case of a pregnant patient who presented with a primary intestinal-type mucinous adenocarcinoma of the ovary and underwent unilateral salpingo-oophorectomy, with no additional surgical or chemotherapy treatment after the histological diagnosis, despite an infiltrative stromal invasion pattern. To the best of our knowledge, no such case has been previously reported. Conservative treatment in this case of early ovarian carcinoma is possible during pregnancy and should be performed in the Department of Gynecological Oncology and Obstetrics of a tertiary referral hospital. Given the possibility of disease recurrence, such patients require strict clinical oncological surveillance, specialized prenatal care, and assistance from a multidisciplinary team to improve the maternal and perinatal outcomes. |
---|---|
Bibliography: | Edited by: Ali Çetin, University of Health Sciences, Türkiye This article was submitted to Obstetrics and Gynecology, a section of the journal Frontiers in Medicine Reviewed by: Angelo Finelli, ULSS 2 Marca Trevigiana, Italy; Ricardo Reis, Barretos Cancer Hospital, Brazil |
ISSN: | 2296-858X 2296-858X |
DOI: | 10.3389/fmed.2023.1138447 |